652160-72-0

Basic information

• Product Name: 2-BROMO-5-FLUORO-3-NITROPYRIDINE
• Synonyms: 2-BROMO-5-FLUORO-3-NITROPYRDINE;LogP
• CAS NO: 652160-72-0
• Molecular Formula: C₅H₂BrFN₂O₂
• Molecular Weight: 220.99
• Product Categories: Fluorine series
• Mol File: 652160-72-0.mol

Chemical Properties

• Boiling Point: 227℃
• Flash Point: 91℃
• Appearance: Pale orange/Solid
• Density: 1.923
• Vapor Pressure: 0.118mmHg at 25°C
• Refractive Index: 1.586
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: -5.67±0.20(Predicted)
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: 2-BROMO-5-FLUORO-3-NITROPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-5-FLUORO-3-NITROPYRIDINE(652160-72-0)
• EPA Substance Registry System: 2-BROMO-5-FLUORO-3-NITROPYRIDINE(652160-72-0)

Safety Data

• Hazardous Substances Data: 652160-72-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
2-Bromo-5-fluoro-3-nitropyridine is used as a building block in the field of organic synthesis for the creation of more complex molecules. Its distinct functional groups allow for various chemical reactions, making it a versatile compound for constructing a wide range of chemical structures.
Used in Chemical Research:
In the realm of chemical research, 2-Bromo-5-fluoro-3-nitropyridine is employed as a subject of study to understand the properties and reactivity of compounds with multiple functional groups. This knowledge can be applied to develop new synthetic methods and improve existing ones, ultimately contributing to the advancement of chemistry.
Used in Pharmaceutical Development:
2-Bromo-5-fluoro-3-nitropyridine is used as a starting material in the development of new pharmaceutical compounds. Its unique structure and reactivity can be harnessed to create potential drug candidates with novel therapeutic properties, offering new treatment options for various medical conditions.
Used in Material Science:
In material science, 2-Bromo-5-fluoro-3-nitropyridine is utilized in the synthesis of new materials with specific properties, such as improved stability or enhanced reactivity. These materials can be used in various applications, including coatings, adhesives, and other industrial products.

InChI:InChI=1/C5H2BrFN2O2/c6-5-4(9(10)11)1-3(7)2-8-5/h1-2H

Upstream product

• 51173-05-8 5-fluoropyridin-2-ol 
• 51173-04-7 5-fluoro-2-methoxypyridine 
• 6628-77-9 6-methoxy-pyridin-3-ylamine 
• 136888-20-5 5-fluoro-2-hydroxy-3-nitropyridine 

Downstream Products

• 446284-50-0 4-fluoro-1H-pyrrolo[2,3-c]pyridine-7-carbonitrile 
• 446284-56-6 4-fluoro-1H-pyrrolo[2,3-c]pyridine-7-carboxylic acid 
• 884494-99-9 2,6-dibromo-5-fluoropyridin-3-amine 
• 1033202-51-5 5-fluoro-3-nitropyridine-2-carbonitrile 
• 1312605-92-7 (7-fluoro-2-(2-(methylsulfonyl)phenyl)-1,5-naphthyridin-3-yl)methanol 
• 1312605-97-2 4-amino-6-((1-(7-fluoro-2-(2-(methylsulfonyl)phenyl)-1,5-naphthyridin-3-yl)ethyl)amino)-5-pyrimidinecarbonitrile 
• 1312605-96-1 1-(7-fluoro-2-(2-(methylsulfonyl)phenyl)-1,5-naphthyridin-3-yl)ethanamine 
• 1312605-95-0 2-(1-(7-Fluoro-2-(2-(methylsulfonyl)phenyl)-1,5-naphthyridin-3-yl)ethyl)isoindoline-1,3-dione 
• 1312605-93-8 7-fluoro-2-(2-(methylsulfonyl)phenyl)-1,5-naphthyridine-3-carbaldehyde 
• 1312605-94-9 methyl (7-fluoro-2-(2-(methylsulfonyl)phenyl)-1,5-naphthyridin-3-yl)methanol 
• 1312605-91-6 Methyl-7-fluoro-2-(2-(methylsulfonyl)phenyl)-1,5-naphthyridine-3-carboxylate 
• 1289114-66-4 3-amino-5-fluoropicolinaldehyde 
• 1289047-69-3 5-fluoro-3-nitropicolinaldehyde 
• 1312605-55-2 4-amino-6-(((1S)-1-(7-fluoro-2-(2-(methylsulfonyl)-phenyl)-1,5-naphthyridin-3-yl)ethyl)amino)-5-pyrimidinecarbonitrile 

Relevant articles and documents

Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 12. Structure-activity relationships associated with 4-fluoro-6-azaindole derivatives leading to the identification of 1-(4-benzoylpiperazin-1-yl)-2-(4- fluoro-7-[1,2,3]triazol-1-yl-1H-

A series of highly potent HIV-1 attachment inhibitors with 4-fluoro-6-azaindole core heterocycles that target the viral envelope protein gp120 has been prepared. Substitution in the 7-position of the azaindole core with amides (12a,b), C-linked heterocycl

Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents

This disclosure provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the disclosure is concerned with new aminium salts of 1,2,3-triazoles which can be used as prodrugs to improve

Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiv

Prodrugs of piperazine and substituted piperidine antiviral agents

This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: X is C or N with the proviso that when X is N, R1 does not exist; W is C or N with the proviso that when W is N, R2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein: L and M are independently selected from the group consisting of C1-C6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy.

Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.

Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with sulfonylureido piperazine derivatives of Formula I. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS. 1wherein: Z is 2Q is selected from the group consisting of: 3—W— is 4—represents a carbon-carbon bond or does not exist; and A is NR13R14.

INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC UREIDO AND THIOUREIDO PIPERAZINE DERIVATIVES

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with ureido and thioureido piperazine derivatives of Formula (I). These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS. The compounds of Formula (I) are Formula (I) wherein:Y is O or S;Z is Formula (II); Q is selected from the group consisting of Formula (A) and Formula (B); m is 2;A is NRR; and-W- is Formula (C).

Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with new piperidine 4-alkenyl derivatives that possess unique antiviral activity. More particularly, the present invention relates to compounds useful for the treatment of HIV and AIDS. The compounds of the invention for the general Formula I: wherein: Z is Q is selected from the group consisting of: —W— is